Progyny Ownership
| PGNY Stock | USD 15.44 0.47 3.14% |
Shares in Circulation | First Issued 2018-09-30 | Previous Quarter 97.8 M | Current Value 93.8 M | Avarage Shares Outstanding 93.6 M | Quarterly Volatility 10.7 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Progyny |
Progyny Stock Ownership Analysis
About 93.0% of the company shares are owned by institutional investors. The book value of Progyny was at this time reported as 4.92. The company had not issued any dividends in recent years. Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York. Progyny operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 311 people. To find out more about Progyny contact Peter Anevski at 212 888 3124 or learn more at https://www.progyny.com.Besides selling stocks to institutional investors, Progyny also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Progyny's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Progyny's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Progyny Quarterly Liabilities And Stockholders Equity |
|
Progyny Insider Trades History
About 7.0% of Progyny are currently held by insiders. Unlike Progyny's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Progyny's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Progyny's insider trades
Progyny Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Progyny is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Progyny backward and forwards among themselves. Progyny's institutional investor refers to the entity that pools money to purchase Progyny's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Riverbridge Partners Llc | 2024-09-30 | 1.7 M | Owls Nest Partners Ia, Llc | 2024-09-30 | 1.5 M | Farallon Capital Management, L.l.c. | 2024-06-30 | 1.3 M | Bank Of America Corp | 2024-06-30 | 1.2 M | Dimensional Fund Advisors, Inc. | 2024-09-30 | 1.1 M | Macquarie Group Ltd | 2024-06-30 | 1.1 M | Northern Trust Corp | 2024-09-30 | 1 M | Kornitzer Capital Management Inc | 2024-09-30 | 976.5 K | Rockefeller Capital Management L.p. | 2024-06-30 | 975.2 K | Blackrock Inc | 2024-06-30 | 11.8 M | Vanguard Group Inc | 2024-09-30 | 8.6 M |
Progyny Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Progyny insiders, such as employees or executives, is commonly permitted as long as it does not rely on Progyny's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Progyny insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Progyny Outstanding Bonds
Progyny issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Progyny uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Progyny bonds can be classified according to their maturity, which is the date when Progyny has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| US74348YAV39 Corp BondUS74348YAV39 | View | |
| PROSPECT CAP P Corp BondUS74348YDU29 | View | |
| US74348YDX67 Corp BondUS74348YDX67 | View | |
| PROSPECT CAP P Corp BondUS74348YEA55 | View | |
| US74348TAU60 Corp BondUS74348TAU60 | View | |
| US74348TAT97 Corp BondUS74348TAT97 | View |
Progyny Corporate Filings
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
8K | 12th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 3rd of October 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10Q | 7th of August 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Progyny Stock Analysis
When running Progyny's price analysis, check to measure Progyny's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Progyny is operating at the current time. Most of Progyny's value examination focuses on studying past and present price action to predict the probability of Progyny's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Progyny's price. Additionally, you may evaluate how the addition of Progyny to your portfolios can decrease your overall portfolio volatility.